N
Niranjan P. Sahu
Researcher at Indian Institute of Chemical Biology
Publications - 64
Citations - 1780
Niranjan P. Sahu is an academic researcher from Indian Institute of Chemical Biology. The author has contributed to research in topics: Triterpene & Mimusops elengi. The author has an hindex of 25, co-authored 64 publications receiving 1666 citations.
Papers
More filters
Journal ArticleDOI
Trigonella foenum graecum (fenugreek) seed extract as an antineoplastic agent.
P. Sur,M. Das,Aparna Gomes,J.R. Vedasiromoni,Niranjan P. Sahu,Soma Banerjee,R.M. Sharma,Dilip K. Ganguly +7 more
TL;DR: Treatment with the extract of Trigonella foenum graecum seed extract was found to enhance both the peritoneal exudate cell and macrophage cell counts and produced a significant antiinflammatory effect.
Journal ArticleDOI
Triterpenoid saponins from Gymnema sylvestre
TL;DR: The aglycone, gymnemanol, which is a new compound, was characterized as 3 beta, 16 beta, 22 alpha, 23, 28-pentahydroxyolean-12-ene.
Journal ArticleDOI
Woodfordia fruticosa: Traditional uses and recent findings
Pratap K. Das,Suchandra Goswami,Annalakshmi Chinniah,Nilendu Panda,Sukdeb Banerjee,Niranjan P. Sahu,Basudeb Achari +6 more
TL;DR: A comprehensive account of the chemical constituents and the biological activities of Woodfordia fruticosa Kurz is presented and a critical appraisal of the ethnopharmacological issues is included in view of the many recent findings of importance on this plant.
Journal ArticleDOI
Flavonol glycosides from Calotropis gigantea.
TL;DR: A new flavonol trisaccharide was isolated from the aerial parts of Calotropis gigantea, and its structure was established as isorhamnetin-3-O-[2-O-beta-D-galactopyranosyl-6- O-alpha-L-rhamnopy ranosyl]- beta-D
Journal ArticleDOI
Synthesis of a Novel Quinoline Derivative, 2-(2-Methylquinolin-4- ylamino)-N-phenylacetamide—A Potential Antileishmanial Agent
Niranjan P. Sahu,Chiranjib Pal,Nirup B. Mandal,Sukdeb Banerjee,Mausumi Raha,Ashis P. Kundu,Anirban Basu,Monidipa Ghosh,Keshab Chandra Roy,Santu Bandyopadhyay +9 more
TL;DR: 2-(2-Methylquinolin-4-ylamino)-N-phenylacetamide (2) was found to be significantly more active than the standard antileishmanial drug sodium antimony gluconate (SAG) in reducing the parasite load both in the spleen and liver at a much lower concentration in hamster models.